Has June Benjamin received payments from drug or device companies?

Yes. Drug and device makers reported $2,943 in general payments to June Benjamin across 150 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean June Benjamin did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about June Benjamin come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

June Benjamin

Family · Reading, PANPI 1093323909

Payments from drug & device makers

$2,943in general payments, 2019–2025

Across 150 payments — averaging $19.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novo Nordisk$1K
Lilly USA, LLC$490
Pfizer$193
Medtronic$192
AstraZeneca$190
Bayer$147
plus $355 from 8 others

What the payments were for

Food & beverage$2,943100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novo Nordisk	55	$1,376
Lilly USA, LLC	34	$490
Pfizer	12	$193
Medtronic	10	$192
AstraZeneca	12	$190
Bayer	8	$147
Merck	7	$126
Boehringer Ingelheim	4	$80
Amneal Pharmaceuticals LLC	3	$61
VBI Vaccine (delaware) Inc.	1	$23
Sanofi Pasteur Inc.	1	$19
Qiagen, LLC	1	$17
GSK	1	$15
Lundbeck LLC	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Wegovy$124

How this compares

$2,943 in reported general payments places this provider in the 85th percentile of 4,717 family providers in Pennsylvania.

See all family providers in Pennsylvania →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
TrulicityDulaglutide	33	$45,621
JardianceEmpagliflozin	49	$41,409
MounjaroTirzepatide	26	$31,842
FarxigaDapagliflozin Propanediol	32	$28,709
OzempicSemaglutide	23	$21,897
EliquisApixaban	22	$20,112
JanuviaSitagliptin Phosphate	18	$15,063
JanumetSitagliptin Phos/Metformin Hcl	15	$10,612
Advair HfaFluticasone Propion/Salmeterol	26	$10,218
DuleraMometasone/Formoterol	21	$7,126
Lantus SolostarInsulin Glargine,hum.Rec.Anlog	35	$3,659
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate	13	$3,557
True Comfort Safety Pen NeedlePen Needle, Diabetic, Safety	11	$2,663
Albuterol Sulfate HfaAlbuterol Sulfate	65	$2,067
Lidocaine	22	$1,935

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro	$490	$77,46359 claims
Boehringer IngelheimJardiance	$80	$41,40949 claims
MerckJanuvia, Janumet, Dulera	$126	$32,80154 claims
AstraZenecaFarxiga	$190	$28,70932 claims
Novo NordiskOzempic	$1,376	$21,89723 claims
PfizerEliquis	$193	$20,11222 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium	$61	$32743 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,717 family providers in Pennsylvania.